GDRX
GoodRx Holdings, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$3.48
−1.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 785.2M | 796.9M | 792.3M | 750.3M | 766.6M |
| Cost of Revenue | 93.8M | 57.6M | 48.2M | 66.9M | 65.1M |
| Gross Profit | 691.4M | 739.3M | 744.1M | 683.3M | 701.5M |
| Operating Expenses | |||||
| R&D Expense | 116.8M | 121.0M | 123.7M | 135.8M | 143.1M |
| SG&A Expense | 432.8M | 445.5M | 485.0M | 466.8M | 502.4M |
| General & Admin Expense | 107.6M | 114.0M | 117.9M | 125.5M | 144.8M |
| Selling & Marketing Expense | 325.2M | 331.6M | 367.1M | 341.3M | 357.6M |
| Other Expenses | 61.3M | 85.2M | 69.5M | 107.7M | 54.2M |
| Total Operating Expenses | 610.9M | 651.8M | 678.3M | 710.3M | 699.7M |
| Cost and Expenses | 704.7M | 709.4M | 726.5M | 777.3M | 764.8M |
| Operating Income (EBIT) | 80.5M | 87.5M | 65.8M | (27.0M) | 1.7M |
| Non-Operating | |||||
| Interest Income | 6.6M | 10.9M | 23.3M | 32.2M | 9.3M |
| Interest Expense | 40.8M | 42.6M | 52.9M | 56.7M | 34.2M |
| Net Interest Income | (34.2M) | (31.7M) | (29.6M) | (24.6M) | (25.0M) |
| Other Non-Op Income/Expense | (39.1M) | (31.0M) | (34.4M) | (28.6M) | (25.0M) |
| Non-Operating Income (excl Interest) | (1.7M) | (11.7M) | (18.5M) | (28.2M) | (9.3M) |
| EBT (Pre-Tax Income) | 41.4M | 56.5M | 31.5M | (55.6M) | (23.2M) |
| Income Tax Expense | 25.1M | 26.1M | 15.1M | (46.7M) | 9.6M |
| Bottom Line | |||||
| Net Income | 16.2M | 30.4M | 16.4M | (8.9M) | (32.8M) |
| Earnings from Cont. Ops | 16.2M | 30.4M | 16.4M | (8.9M) | (32.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 16.2M | 30.4M | 16.4M | (8.9M) | (32.8M) |
| Per Share | |||||
| Basic EPS | $0.05 | $0.09 | $0.04 | ($0.02) | ($0.08) |
| Diluted EPS | $0.04 | $0.09 | $0.04 | ($0.02) | ($0.08) |
| Revenue Per Share | $2.31 | $2.24 | $2.05 | $1.83 | $1.86 |
| Shares | |||||
| Basic Shares Outstanding | 339.3M | 356.3M | 385.7M | 410.3M | 412.9M |
| Diluted Shares Outstanding | 348.1M | 357.0M | 392.2M | 410.3M | 412.9M |
| Profitability Metrics | |||||
| EBITDA | 148.6M | 184.4M | 153.9M | 108.8M | 65.2M |
| D&A | 66.4M | 85.2M | 69.5M | 107.7M | 54.2M |
| EBIT | 82.2M | 99.1M | 84.4M | 1.2M | 11.0M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026